We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Section A: Submissions for registration
The committee provided advice on one submission:
- Provisional registration of new vaccine Comirnaty Original / Omicron BA.4-5, containing tozinameran and famtozinameran, to prevent COVID-19 (sponsor Pfizer Australia Pty Ltd).
Details of the ACV advice associated with premarket items has been or will be released within the Australian Public Assessment Report (AusPAR). To browse all AusPARs see AusPAR search.
Section B: Safety
The committee was not asked to provide advice on any safety matter.
Further information
For further information on the ACV, please visit Advisory Committee on Vaccines
or contact the ACV by email ACV@health.gov.au.